Differences in proviral DNA load between HIV-1- and HIV-2-infected patients

AIDS

Volumn 22, Issue 2, 2008, Pages 211-215

  Gueudin, Marie ^a   Damond, Florence ^b   Braun, Joséphine ^a   Taïeb, Audrey ^c   Lemée, Véronique ^a   Plantier, Jean Christophe ^a   Chêne, Geneviève ^c   Matheron, Sophie ^b   Brun Vézinet, Françoise ^b   Simon, François ^a,d  

^a HÔPITAL CHARLES NICOLLE   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; DNA, VIRAL; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; LEUKOCYTES, MONONUCLEAR; PLASMIDS; POLYMERASE CHAIN REACTION; PROVIRUSES; TERMINAL REPEAT SEQUENCES; VIRAL LOAD;

EID: 37549002876     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f42429     Document Type: Article

References (20)

1. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira MO, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233:343-346.
2. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses 2002; 18:1167-1173.
3. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286-3293.
4. Shanmugam V, Switzer WM, Nkengasong JN, Garcia-Lerma G, Green TA, Ekpini E, et al. Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. J Acquir Immune Defic Syndr 2000; 24:257-263.
5. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, Coll-Seck AM, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905-914.
6. Damond F, Descamps D, Farfara I, Telles JN, Puyeo S, Campa P, et al. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol 2001; 39:4264-4268.
7. Berry N, Ariyoshi K, Jobe O, Ngum PT, Corrah T, Wilkins A, et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994; 10:1031-1037.
8. Sarr AD, Popper S, Thior I, Hamel DJ, Sankale JL, Siby T, et al. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J Hum Virol 1999; 2:45-51.
9. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pepin JM, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7:1411-1417.
10. Gueudin M, Damond F, Simon F. Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. Methods Mol Biol 2005; 304:215-220.
11. Viard JP, Burgard M, Hubert JB, Aaron L, Rabian C, Pertuiset N, et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 2004; 18:45-49.
12. Pellegrin I, Caumont A, Garrigue I, Merel P, Schrive MH, Fleury H, et al. Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy. J Infect Dis 2003; 187: 38-46.
13. Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, et al. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol 2002; 40:3654-3659.
14. Damond F, Collin G, Descamps D, Matheron S, Pueyo S, Taieb A, et al. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J Clin Microbiol 2005; 43:4234-4236.
15. MacNeil A, Sarr AD, Sankale JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol 2007; 81:5325-5330.
16. Goujard C, Bonarek M, Meyer L, Bonnet F, Chaix ML, Deveau C, et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006; 42:709-715.
17. Damond F, Apetrei C, Robertson DL, Souquiere S, Lepretre A, Matheron S, et al. Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in france. Virology 2001; 280:19-30.
18. Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 2005; 192:46-55.
19. Comandini UV, Sonnerborg A, Vahlne A, Yun Z. Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR. J Virol Methods 1997; 69:171-180.
20. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506.